Saluda Medical: revenue up 26%, record U.S. implants, but new funding needed
Saluda Medical's first-quarter revenue rose 26% and U.S. implants hit a record. Cash runway reaches only about June 2027.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, Saluda Medical's first-quarter revenue grew 26% year on year. U.S. implants rose 55% to a record 838. The company reaffirmed its guidance for fiscal 2027.
At the same time, its cash runway extends only to about June 2027, so the company will need additional capital.
why it matters
For shareholders, the key issue now is not sales growth but how and on what terms the company will raise funding. The need for new capital typically weighs on a stock more than quarterly operating figures do.
tags
instruments
sources
- Saluda Medical: Revenue grew 26%; record U.S. implants met reaffirmed guidance amid near-term funding needs — TradingView, 29 October 2026 at 02:36 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗